Zika Virus RNA, Qualitative TMA Panel, Serum/Urine
Also known as: ZIKA VIRUS URINE SERUM PANEL
Use
This test is intended for the qualitative detection of Zika virus RNA to aid in diagnosing Zika virus infection during the acute phase. Serum and urine specimens collected on the same date are required, reflecting CDC-recommended paired specimen testing for molecular detection.
Special Instructions
Both serum and urine, with the same collection date, are required for each patient. Order separately from other tests on a separate requisition. Follow specific collection instructions for serum and urine (detailed below).
Limitations
Not provided.
Methodology
NGS
Biomarkers
Result Turnaround Time
1 day
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
3 mL
Minimum Volume
1.5 mL
Container
Serum separator tube or standard red-top, serum transferred to plastic tube
Collection Instructions
Collect blood in serum separator tube (preferred) or red-top; allow to clot; centrifuge ASAP; transfer serum to new aliquot tube.
Other tests from different labs that may be relevant